Changchun BCHT Biotechnology Co.

Changchun BCHT Biotechnology Co.

[email protected]

86-

Changchun BCHT Biotechnology Co.

All
  • All
  • Title
Language

Changchun BCHT Biotechnology Co.

 [Jilin,China]

Business Type:Manufacturer

Main Markets: Asia

Exporter:1% - 10%

Certs:GMP

Description:Protective Efficacy Safety Immunogenicity,Age Group of Subjects,Recommanded Influenza Vaccine

HomeProductsInfluenza VaccineBCHT Influenza Vaccine Global Information
Contact Supplier
Flora Zhang

Ms. Flora Zhang

Leave a message
Contact Now
BCHT Influenza Vaccine Global Information
  • BCHT Influenza Vaccine Global Information
  • BCHT Influenza Vaccine Global Information
  • BCHT Influenza Vaccine Global Information

BCHT Influenza Vaccine Global Information

Payment Type:
L/C,T/T
Incoterm:
FOB,CFR,CIF,CIP
Min. Order:
/Bags
Transportation:
Air
Contact Now
Share:
  • Product Description
< >
Overview
Product Attributes

Model No.: Ampoule

Brand: BCHT

Ampoule: 0.2ml

Supply Ability & Additional Information

Packaging: in vial

Productivity: 10 million / year

Transportation: Air

Place of Origin: China

Supply Ability: Excellent

Certificate: GMP in China

HS Code: 300220

Payment Type: L/C,T/T

Incoterm: FOB,CFR,CIF,CIP

Packaging & Delivery
Selling Units:
Bag/Bags
Package Type:
in vial
In 2020, BCHT launched its Influenza Vaccine, Live, Nasal, Freeze-dried which is exclusively authorized by the WHO in China. Objective: Protective efficacy（Main indicator） Safety（Expand the population） Immunogenicity（Exploring） Design: multicenter, randomized, double-blind. Sample size: 9000 people, 1：1 Age group of subjects: 3-17 years old Protective efficacy: Collection of influenza like cases - laboratory test endpoint...

Product Categories : Influenza Vaccine

Download
Hot Products
Email to this supplier
  • *To:
    Ms. Flora Zhang
  • *Message:
    Your message must be between 20-8000 characters
Contact Now
HomeProductsInfluenza VaccineBCHT Influenza Vaccine Global Information
Send Inquiry
*
*

Related Products List
Protective Efficacy Safety Immunogenicity Age Group of Subjects Recommanded Influenza Vaccine High Potency and Good Immunogenicity High Protection Cross Immunity Live Good Safety Preventive

Home

Product

Phone

About Us

Inquiry